Case Report
Accepted on 28 Jul 2025
Golidocitinib was used for the first time to treat refractory NK-Large Granular Lymphocytic Leukemia with a STAT3 mutation, accompanied by hemolytic anemia:A Case Report
in Cancer Immunity and Immunotherapy
Case Report
Accepted on 28 Jul 2025
in Cancer Immunity and Immunotherapy
Correction
Accepted on 28 Jul 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 28 Jul 2025
in Biomaterials
Review
Accepted on 28 Jul 2025
in Inflammation
Review
Accepted on 28 Jul 2025
in Animal Nutrition and Metabolism
Original Research
Accepted on 28 Jul 2025
in Radiation Oncology
Case Report
Accepted on 28 Jul 2025
in Surgical Oncology
Review
Accepted on 28 Jul 2025
in Biomaterials
Original Research
Accepted on 28 Jul 2025
in Animal Behavior and Welfare
Systematic Review
Accepted on 28 Jul 2025
in Gastroenterology
Original Research
Accepted on 28 Jul 2025
in Terrestrial Microbiology
Review
Accepted on 28 Jul 2025
in Antimicrobials, Resistance and Chemotherapy
Opinion
Accepted on 28 Jul 2025
in Interventions for Rehabilitation
Original Research
Accepted on 28 Jul 2025
in Brain Imaging Methods
Original Research
Accepted on 28 Jul 2025
in Microbiotechnology
Review
Accepted on 28 Jul 2025
in Animal Behavior and Welfare